Edward Miller Net Worth & Insider Trades
Edward Miller - SVP, Alexion Pharmaceuticals Inc
What is Edward Miller's Net Worth?
The current estimated net worth of Alexion Pharmaceuticals Inc's SVP, Edward Miller, is estimated to be about $2.91M . Edward Miller owns about 19,284 units of Alexion Pharmaceuticals Inc common stock. In the last 3 years at Alexion Pharmaceuticals Inc, Edward Miller has sold an estimated value of $517.75K worth.
What is Edward Miller's Past Insider Trading?
Edward Miller's largest sale order was 1,051 units , worth over $150.31K on February 8, 2016. In total, Edward Miller has made about 8 transactions over 3 years of their time at Alexion Pharmaceuticals Inc. Edward Miller usually trades in March and September, with the busiest year in 2016. The most recent transaction was a sale order of 590 units , worth over $77.57K on March 1, 2017.
Edward Miller
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Edward Miller's' Mailing Address?
- Mailing address is C/o Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410 CT
Alexion Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Ludwig Hantson | 2019 | $1,250,000 | - | $15,243,634 | - | $2,430,000 | $24,350 | $18,947,984 |
Ludwig Hantson | 2018 | $1,200,000 | - | $12,385,168 | - | $2,880,000 | $25,082 | $16,490,250 |
Ludwig Hantson | 2017 | $900,000 | - | $9,618,758 | $2,282,881 | $2,275,000 | $233,428 | $15,310,067 |
Aradhana Sarin | 2019 | $651,764 | - | $3,380,763 | - | $813,011 | $31,604 | $4,877,142 |
Paul Clancy | 2019 | $927,000 | - | $3,863,694 | - | $1,051,218 | $23,832 | $5,865,744 |
Paul Clancy | 2018 | $900,000 | - | $3,302,761 | - | $1,260,000 | $23,752 | $5,486,513 |
Paul Clancy | 2017 | $415,385 | $500,000 | $8,799,954 | $1,220,082 | $473,620 | $2,262 | $11,411,303 |
Brian Goff | 2019 | $740,000 | - | $3,863,694 | - | $923,076 | $20,240 | $5,547,010 |
Brian Goff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $111,873 | $4,876,796 |
Brian Goff | 2017 | $381,634 | $100,000 | $2,390,026 | $732,899 | $434,380 | $58,787 | $4,097,726 |
Anne-Marie Law | 2019 | $695,000 | - | $3,622,303 | - | $788,130 | $33,528 | $5,138,961 |
Anne-Marie Law | 2018 | $650,000 | - | $2,889,885 | - | $910,000 | $846,604 | $5,296,489 |
Anne-Marie Law | 2017 | $362,500 | $200,000 | $2,300,015 | - | $410,472 | $68,710 | $3,341,697 |
John Orloff | 2019 | $770,000 | - | $3,863,694 | - | $960,498 | $32,550 | $5,626,742 |
John Orloff | 2018 | $695,250 | - | $3,096,323 | - | $973,350 | $98,679 | $4,863,602 |
John Orloff | 2017 | $376,442 | $200,000 | $2,499,995 | - | $472,500 | $80,351 | $3,629,288 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm
What are Alexion Pharmaceuticals Inc's Past Insider Trades?
Alexion Pharmaceuticals Inc's most recent insider trade came on December 21, 2020 by Daniel Bazarko who sold 24,066 units worth $3.8M . In the last 17 years, insiders at Alexion Pharmaceuticals Inc have sold an estimated value of $1.09B and bought an estimated value of $426.64M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Leonard Bell, Director, Stephen Squinto, EVP, and Vikas Sinha, EVP & CFO .
ALEXION PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |